Researchers linked to the Federal Institute of Technology in Zurich, located in Switzerland, have designed a pioneering mechanism capable of tracking the elimination of adipose tissue just by analyzing the air exhaled by the patient. This technological innovation appears as a game changer for individuals undergoing obesity treatment and professionals focused on fine-tuning human metabolism. Historically, measuring lipid oxidation required invasive blood tests or uncomfortable urine strips, which made daily monitoring impractical for most people. Now, replacing these methods with a simple exhalation promises to democratize access to complex physiological data, facilitating the understanding of how the body reacts to different food stimuli. The technical details and chemical foundations of this medical engineering were officially published in the renowned scientific journal Device, in an edition released on July 22, 2026.

Commercially called Nutrion, the equipment has an anatomical and portable design that closely resembles the traditional traffic breathalyzers used by police authorities, but its exclusive function is to quantify the presence of acetone in the air leaving the lungs. When this specific molecule appears in high concentration in the respiratory tract, it means that the body has abandoned circulating glucose and started burning deep fat stores in order to survive and keep the organs functioning. During the initial clinical validation phase, scientists conducted a battery of rigorous tests with 12 volunteer participants, monitoring their reactions over several weeks. The result demonstrated that the accuracy of the reading made by the portable device is practically identical to conventional laboratory tests, validating the effectiveness of the miniaturized biosensor.

Internal Swiss sensor mechanism ensures high precision in breath capture

Nutrion’s architecture depends on a disposable and hygienic mouthpiece through which the patient exhales, directing the airflow directly to a biosensor highly sensitive to the presence of acetone. Inside the hardware structure, materials engineers applied a special polymeric coating that can capture gas molecules for fractions of a second longer than ordinary sensors. This intelligent chemical barrier acts as a purifying filter, separating the target compound from saliva droplets, water vapor and other respiratory impurities that could mask the result. Thanks to this thermal and chemical insulation, the processor is able to deliver a diagnosis with no margin for error, even in environments with high relative humidity.

Full coverage: Latest News (EN)

To avoid human error during the collection of biological material, the developers integrated the hardware with an intuitive smartphone application that guides the user step by step throughout the clinical procedure. The digital interface shows on the cell phone screen the exact force that the lungs must apply to the tube, creating a visual graph that helps the patient maintain a constant and uninterrupted air flow.

This same mobile software emits a visual and audible alert at the perfect millisecond in which the air sample reaches the ideal volume within the analysis chamber, ensuring that the sensor reads exactly at the peak of deep exhalation. This digital control eliminates the risk of superficial samples, which generally only carry air from the trachea and do not reflect the real gas exchange that occurs in the pulmonary alveoli.

Based on this perfect synchrony between human breath and digital processing, the system’s intelligence tracks acetone particles with nanometric precision. This volatile compound functions as a natural byproduct made by the liver every time the human body exhausts its reserves of fast carbohydrates and needs to break down complex fatty acids to generate emergency cellular energy.

The volume of this gas exhaled through the mouth works, in practice, as an exact thermometer of the state of ketosis, revealing in a completely non-invasive way that the metabolism has entered the phase of melting the fat stored in adipose tissue. Understanding this metabolic transition is the main objective of endocrinologists, as it indicates that the body stopped storing calories and started using its own weight as the primary fuel for daily activities.

Follow: all about Federal Institute of Technology Zurich

Scientist Andreas Güntner, senior researcher who led the construction of the prototype at the Swiss institution, explained that the machine’s extreme sensitivity captures metabolic fluctuations in real time, something unprecedented in sports medicine. The specialist reported that, immediately after intense sessions of physical activity, the equipment’s display showed an immediate jump in acetone production, proving the effectiveness of the exercise. However, he observed an impressive reverse phenomenon: the volunteer simply had to drink a glass of sweetened juice or eat a meal rich in simple carbohydrates for the levels to instantly plummet, interrupting lipid burning at the same time.

The project leader highlighted that this instant monitoring capability turns the equipment into a powerful ally for nutrition clinics looking to safely extend their patients’ ketosis window. The technology delivers concrete data in real time and is fundamental in the daily support of several modern therapeutic approaches, including the following areas of activity:

• Strict monitoring of the metabolic response in treatments that use GLP-1 class drugs to control appetite.
• Daily monitoring of strict adherence to eating plans based on the ketogenic diet, preventing the patient from leaving the burning state.
• Detailed assessment of physiological performance and energy expenditure during high-intensity physical training routines.

Despite the absolute success in the prototyping phase and the promising results published in the medical literature, the device will still take a while to reach the shelves of pharmacies and doctors’ offices. The breeders are now preparing a new round of large-scale clinical trials, involving varied genetic profiles and different age groups. This stage of exhaustive testing is a mandatory bureaucratic and scientific step for international health regulatory agencies to certify the invention as a safe medical instrument, allowing its mass manufacturing and global commercialization in the coming years.